Eli Lilly has rolled out Foundayo, its oral GLP-1 pill, directly to consumers through its LillyDirect cash-pay channel, as well as to telehealth providers and pharmacies across the U.S. The drug is a ...

HOUSTON — The Food and Drug Administration gave its blessing to a new GLP-1 pill last week, and Houston will play a role in its manufacturing. Orforglipron, under the brand name Foundayo, received FDA ...

Eli Lilly (LLY) generated $65.18B in full-year 2025 revenue, up 44.7% year-over-year, driven by its GLP-1 franchises Mounjaro and Zepbound which command 60% of the weight-loss market, with 2026 ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...

Eli Lilly, the Indianapolis-based pharmaceutical company, officially received approval from the Food and Drug Administration for a new weight-loss pill on April 1. The company shared in a press ...

The U.S. Food and Drug Administration on Wednesday gave its approval to Eli Lilly’s GLP-1 weight loss pill. The daily pill, called Foundayo, is the second oral GLP-1 product to reach the market over ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA has approved two GLP-1 oral medications, including one by Eli Lilly on Wednesday. File Photo by Jim Lo Scalzo/EPA April 1 ...

CNBC's Angelica Peebles reports the latest news surrounding GLP-1 drugs. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox ...

Eli Stowers didn't use Vanderbilt football's pro day as a second showcase point for the record-breaking performances at the 2026 NFL Scouting Combine. Less than a month removed from vertical leaping ...